Search Results

READ THE COMPLETE PRESS RELEASE

Preliminary Fourth Quarter Total Sales Increase 30% to 36% year-over-year; U.S. Sales up 34% to 38% year-over-year and up 20% to 23%...

Mauna Kea Technologies today announced that management will participate in the following upcoming investor conferences in January:  The...

Mauna Kea Technologies announced today the cooptation by the Board of Ms. Jacquelien ten Dam as an Independent Director, effective immediately....

The IRiS Alliance is an exclusive scientific and clinical research collaboration that combines two highly complementary technologies to deliver...

Further peer-reviewed evidence that using Cellvizio as an adjunct to the standard of care can significantly improve the speed and accuracy of...

Third Quarter Total Sales Increase 13% year-over-year; U.S. Sales up 7%  First Nine Months Total Sales Decrease 28% year-over-year; Significant...

1H’20 financial results driven primarily by a 10% reduction in total operating expenses (without COGS) and a 17% reduction in net loss...

Company to host business update conference call on Tuesday, September 22, 2020, at 6:00 PM CEST (Paris time) / 1:00 PM (New York time)  Mauna...

Mauna Kea Technologies announced today the appointment of Claire Biot, Ph.D., as an Independent Director, effective immediately. Dr Claire Biot...

First Half of 2020 total sales down 47%; U.S. sales down 19%  Second Quarter total sales down 72%; U.S. sales down 47%  Sufficient...

Mauna Kea Technologies announced that it has received financing approvals from BNP Paribas and Bpifrance for a total of €4 million in...